Now that Heron Therapeutics Inc’s volume has hit 3.12 million, investors get a glimpse of its size.

On Monday, Heron Therapeutics Inc (NASDAQ: HRTX) opened higher 8.23% from the last session, before settling in for the closing price of $2.43. Price fluctuations for HRTX have ranged from $0.50 to $2.95 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

A company in the Healthcare sector has jumped its sales by 17.81% annually for the last half of the decade. Company’s average yearly earnings per share was noted 48.07% at the time writing. With a float of $147.62 million, this company’s outstanding shares have now reached $150.07 million.

Heron Therapeutics Inc (HRTX) Insider Updates

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Heron Therapeutics Inc is 1.64%, while institutional ownership is 80.38%. The most recent insider transaction that took place on Nov 17, was worth 27,250. In this transaction EVP, Chief Development Officer of this company bought 25,000 shares at a rate of $1.09, taking the stock ownership to the 79,000 shares. Before that another transaction happened on Nov 16, when Company’s Chief Executive Officer bought 150,000 for $0.92, making the entire transaction worth $137,970. This insider now owns 186,496 shares in total.

Heron Therapeutics Inc (HRTX) Performance Highlights and Predictions

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.17 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.29) by $0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 48.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.50% during the next five years compared to 14.46% growth over the previous five years of trading.

Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators

Check out the current performance indicators for Heron Therapeutics Inc (HRTX). In the past quarter, the stock posted a quick ratio of 1.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.21.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.97, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.39 in one year’s time.

Technical Analysis of Heron Therapeutics Inc (HRTX)

Let’s dig in a bit further. During the last 5-days, its volume was 1.91 million. That was inferior than the volume of 3.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 60.60%. Additionally, its Average True Range was 0.20.

During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 94.25%, which indicates a significant increase from 78.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.62% in the past 14 days, which was lower than the 127.96% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.98, while its 200-day Moving Average is $1.46. However, in the short run, Heron Therapeutics Inc’s stock first resistance to watch stands at $2.75. Second resistance stands at $2.88. The third major resistance level sits at $3.03. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.32. Assuming the price breaks the second support level, the third support level stands at $2.19.

Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats

There are currently 150,073K shares outstanding in the company with a market cap of 394.68 million. Presently, the company’s annual sales total 107,670 K according to its annual income of -182,020 K. Last quarter, the company’s sales amounted to 31,430 K and its income totaled -25,010 K.